China Biopsy Procedures Outlook to 2023

China Biopsy Procedures Outlook to 2023

Summary

GlobalDatas new report, "China Biopsy Procedures Outlook to 2023", provides key procedures data on the China Biopsy Procedures. The report provides procedure volumes within market segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology based models to estimate and forecast the procedure volumes. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the procedure volumes.

Scope

- China Biopsy Procedures volumes by segments - Breast Biopsy Procedures, Colorectal Biopsy Procedures, Leukemia Biopsy Procedures, Liver Biopsy Procedures, Lung Biopsy Procedures, Other Indications Biopsy Procedures, Prostate Biopsy Procedures and Thyroid Biopsy Procedures.
- Projections for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.

Reasons to buy

- Develop business and investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Develop market-entry and market expansion strategies.

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Introduction 4
2.1 What Is This Report About? 4
2.2 Biopsy Procedures, Segmentation 4
2.3 Definitions of Procedures Covered in the Report 5
3 Biopsy Procedures, China 7
3.1 Biopsy Procedures, China, 2009-2016 7
3.2 Biopsy Procedures, China, 2016-2023 9
3.2.1 Breast Biopsy Procedures, China, 2009-2016 11
3.2.2 Colorectal Biopsy Procedures, China, 2009-2016 13
3.2.3 Leukemia Biopsy Procedures, China, 2009-2016 15
3.2.4 Liver Biopsy Procedures, China, 2009-2016 16
3.2.5 Lung Biopsy Procedures, China, 2009-2016 18
3.2.6 Other Indications Biopsy Procedures, China, 2009-2016 19
3.2.7 Prostate Biopsy Procedures, China, 2009-2016 21
3.2.8 Thyroid Biopsy Procedures, China, 2009-2016 23
3.2.9 Breast Biopsy Procedures, China, 2016-2023 24
3.2.10 Colorectal Biopsy Procedures, China, 2016-2023 26
3.2.11 Leukemia Biopsy Procedures, China, 2016-2023 28
3.2.12 Liver Biopsy Procedures, China, 2016-2023 29
3.2.13 Lung Biopsy Procedures, China, 2016-2023 31
3.2.14 Other Indications Biopsy Procedures, China, 2016-2023 32
3.2.15 Prostate Biopsy Procedures, China, 2016-2023 34
3.2.16 Thyroid Biopsy Procedures, China, 2016-2023 36
4 Appendix 37
4.1 Research Methodology 38
4.1.1 Coverage 38
4.1.2 Secondary Research 38
4.1.3 Primary Research 39
4.1.4 Market Modeling and Forecasting 40
4.1.5 Company Share Analysis 41
4.1.6 Distribution Share Analysis 42
4.1.7 Benchmarking 42
4.2 GlobalData Consulting 42
4.3 Contact Us 43
4.4 Disclaimer 43

List Of Tables

Table 1: Biopsy Procedures, China, Historic, 2009-2016 8
Table 2: Biopsy Procedures, China, Forecast, 2016-2023 10
Table 3: Breast Biopsy Procedures, China, Historic, 2009-2016 12
Table 4: Colorectal Biopsy Procedures, China, Historic, 2009-2016 14
Table 5: Leukemia Biopsy Procedures, China, Historic, 2009-2016 15
Table 6: Liver Biopsy Procedures, China, Historic, 2009-2016 17
Table 7: Lung Biopsy Procedures, China, Historic, 2009-2016 18
Table 8: Other Indications Biopsy Procedures, China, Historic, 2009-2016 20
Table 9: Prostate Biopsy Procedures, China, Historic, 2009-2016 22
Table 10: Thyroid Biopsy Procedures, China, Historic, 2009-2016 23
Table 11: Breast Biopsy Procedures, China, Forecast, 2016-2023 25
Table 12: Colorectal Biopsy Procedures, China, Forecast, 2016-2023 27
Table 13: Leukemia Biopsy Procedures, China, Forecast, 2016-2023 28
Table 14: Liver Biopsy Procedures, China, Forecast, 2016-2023 30
Table 15: Lung Biopsy Procedures, China, Forecast, 2016-2023 31
Table 16: Other Indications Biopsy Procedures, China, Forecast, 2016-2023 33
Table 17: Prostate Biopsy Procedures, China, Forecast, 2016-2023 35
Table 18: Thyroid Biopsy Procedures, China, Forecast, 2016-2023 36
Table 19: Total Number of Primary Research Participants, General Surgery Market, by Country 40

List Of Figures

Figure 1: Biopsy Procedures, China, Historic, 2009-2016 7
Figure 2: Biopsy Procedures, China, Forecast, 2016-2023 9
Figure 3: Breast Biopsy Procedures, China, Historic, 2009-2016 11
Figure 4: Colorectal Biopsy Procedures, China, Historic, 2009-2016 13
Figure 5: Leukemia Biopsy Procedures, China, Historic, 2009-2016 15
Figure 6: Liver Biopsy Procedures, China, Historic, 2009-2016 16
Figure 7: Lung Biopsy Procedures, China, Historic, 2009-2016 18
Figure 8: Other Indications Biopsy Procedures, China, Historic, 2009-2016 19
Figure 9: Prostate Biopsy Procedures, China, Historic, 2009-2016 21
Figure 10: Thyroid Biopsy Procedures, China, Historic, 2009-2016 23
Figure 11: Breast Biopsy Procedures, China, Forecast, 2016-2023 24
Figure 12: Colorectal Biopsy Procedures, China, Forecast, 2016-2023 26
Figure 13: Leukemia Biopsy Procedures, China, Forecast, 2016-2023 28
Figure 14: Liver Biopsy Procedures, China, Forecast, 2016-2023 29
Figure 15: Lung Biopsy Procedures, China, Forecast, 2016-2023 31
Figure 16: Other Indications Biopsy Procedures, China, Forecast, 2016-2023 32
Figure 17: Prostate Biopsy Procedures, China, Forecast, 2016-2023 34
Figure 18: Thyroid Biopsy Procedures, China, Forecast, 2016-2023 36

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available